First Time Loading...

Hologic Inc
NASDAQ:HOLX

Watchlist Manager
Hologic Inc Logo
Hologic Inc
NASDAQ:HOLX
Watchlist
Price: 77.35 USD 1.55% Market Closed
Updated: Mar 28, 2024

Intrinsic Value

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. [ Read More ]

The intrinsic value of one HOLX stock under the Base Case scenario is 64.48 USD. Compared to the current market price of 77.35 USD, Hologic Inc is Overvalued by 17%.

Key Points:
HOLX Intrinsic Value
Base Case
64.48 USD
Overvaluation 17%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Hologic Inc

Backtest HOLX Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling HOLX stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

How can I assist you today?

Provide an overview
of Hologic Inc's business.

What risks and challenges
does Hologic Inc face in the near future?

Summarize the latest earnings report
of Hologic Inc.

Provide P/E
for Hologic Inc and its competitors.

Financials

Balance Sheet Decomposition
Hologic Inc

Current Assets 3.5B
Cash & Short-Term Investments 1.9B
Receivables 670.9m
Other Current Assets 891.2m
Non-Current Assets 5B
PP&E 527m
Intangibles 4.1B
Other Non-Current Assets 309.7m
Current Liabilities 899m
Accounts Payable 183.8m
Accrued Liabilities 484m
Other Current Liabilities 231.2m
Non-Current Liabilities 2.9B
Long-Term Debt 2.5B
Other Non-Current Liabilities 379.3m
Efficiency

Earnings Waterfall
Hologic Inc

Revenue
4B USD
Cost of Revenue
-1.8B USD
Gross Profit
2.2B USD
Operating Expenses
-1.3B USD
Operating Income
904.3m USD
Other Expenses
-389.2m USD
Net Income
515.1m USD

Free Cash Flow Analysis
Hologic Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

HOLX Profitability Score
Profitability Due Diligence

Hologic Inc's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
Exceptional 3-Year Average ROE
Positive Gross Profit
Positive Operating Income
64/100
Profitability
Score

Hologic Inc's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

HOLX Solvency Score
Solvency Due Diligence

Hologic Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
High Altman Z-Score
Low D/E
Long-Term Solvency
69/100
Solvency
Score

Hologic Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HOLX Price Targets Summary
Hologic Inc

Wall Street analysts forecast HOLX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HOLX is 86.19 USD with a low forecast of 76.76 USD and a high forecast of 99.75 USD.

Lowest
Price Target
76.76 USD
1% Downside
Average
Price Target
86.19 USD
11% Upside
Highest
Price Target
99.75 USD
29% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

HOLX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

HOLX Price
Hologic Inc

1M 1M
+4%
6M 6M
+10%
1Y 1Y
-2%
3Y 3Y
+4%
5Y 5Y
+63%
10Y 10Y
+268%
Annual Price Range
77.35
52w Low
65.11
52w High
87.67
Price Metrics
Average Annual Return 13.33%
Standard Deviation of Annual Returns 18.5%
Max Drawdown -46%
Shares Statistics
Market Capitalization 18.1B USD
Shares Outstanding 234 732 000
Percentage of Shares Shorted 3.49%

HOLX Return Decomposition
Main factors of price return

What is price return decomposition?

HOLX News

Other Videos

Last Important Events
Hologic Inc

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Hologic Inc

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Hologic Inc Logo
Hologic Inc

Country

United States of America

Industry

Health Care

Market Cap

18.1B USD

Dividend Yield

0%

Description

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. The company is headquartered in Marlborough, Massachusetts and currently employs 6,705 full-time employees. The firm operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Diagnostics segment offers a range of diagnostics products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a portfolio of solutions for breast cancer care for radiology, pathology and surgery. The GYN Surgical segment offers a range of products, including its NovaSure Endometrial Ablation System and MyoSure Hysteroscopic Tissue Removal System as well as its Fluent Fluid Management system. The Skeletal Health segment offers products such as the Horizon DXA, a dual energy x-ray system, which evaluates bone density and performs body composition assessments, and the Fluoroscan Insight FD mini C-arm.

Contact

MASSACHUSETTS
Marlborough
250 Campus Dr
+15082632900.0
https://www.hologic.com/

IPO

1990-03-01

Employees

6 705

Officers

Chairman, CEO & President
Mr. Stephen P. MacMillan
Chief Financial Officer
Ms. Karleen M. Oberton
Chief Operating Officer
Mr. Essex D. Mitchell
General Counsel
Mr. John M. Griffin
Group President of International
Mr. Jan Verstreken
Chief Information Officer
Mr. Paul Malenchini
Show More
Vice President of Investor Relations
Ryan M. Simon
Senior Vice President of Human Resources
Mr. Peter P. Dunne
VP & Chief of Staff
Ms. Monica Aguirre Berthelot
Division President of Breast & Skeletal Health Solutions
Mr. Erik S. Anderson
Show Less

See Also

Discover More
What is the Intrinsic Value of one HOLX stock?

The intrinsic value of one HOLX stock under the Base Case scenario is 64.48 USD.

Is HOLX stock undervalued or overvalued?

Compared to the current market price of 77.35 USD, Hologic Inc is Overvalued by 17%.